Review article · 2025 · Open access
Innovative strategies for T cell engagers for cancer immunotherapy
mAbs, 17(1), 2531223 · Published 10 July 2025 · DOI 10.1080/19420862.2025.2531223
In brief
“Innovative strategies for T cell engagers for cancer immunotherapy” is a 2025 review article by Cristina Bergamaschi and 6 co-authors, published in mAbs. OpenAlex counts 43 citations as of 18 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY-NC licence: the full text is free to read at mAbs.
- Citations
- 43
- Most cited in
- 2026 (36)
- Field-weighted impact
- 4.21
- References
- 141
- Authors
- 7
Abstract
T cell engagers (TCEs) are a promising class of cancer immunotherapy that re-direct T cells to kill tumor cells. However, their clinical application is limited by several challenges, including cytokine release syndrome (CRS), on-target off-tumor toxicity and overcoming immunosuppression in both hematological and solid tumors. This review explores recent innovations in TCE design aimed at improving their safety and efficacy. Key developments include optimizing geometry to facilitate effective immune synapses, affinity optimization of the anti-CD3/TCR domain and targeting of specific T cell subsets which both aim to reduce CRS. Logic-gated approaches such as dual-targeted and conditional TCEs activated by tumor microenvironment factors have the potential to reduce on target, off tumor toxicity and potentially increase the depth and durability of response. Additionally, leveraging costimulatory signaling offers the potential to further improve efficacy across hematological and solid tumor settings. The next generation of TCEs is expected to overcome some of the limitations of conventional TCEs, enhancing their therapeutic window and enabling combination therapies. As the field advances, TCEs are poised to become a cornerstone of cancer immunotherapy, potentially improving outcomes for a broader range of patients than the ones currently benefiting from conventional immunotherapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bergamaschi, C., Gaspar, M. A., Ciucci, T., Sitnikova, S. I., Cayatte, C., Pica, M., & Dovedi, S. J. (2025). Innovative strategies for T cell engagers for cancer immunotherapy. mAbs, 17(1), 2531223. https://doi.org/10.1080/19420862.2025.2531223
MLA 9
Bergamaschi, Cristina, et al. “Innovative strategies for T cell engagers for cancer immunotherapy.” mAbs, vol. 17, no. 1, 2025, p. 2531223. https://doi.org/10.1080/19420862.2025.2531223.
Chicago
Bergamaschi, Cristina, Miguel A. Gaspar, Thomas Ciucci, Suzanne I. Sitnikova, Corinne Cayatte, Mike Pica, and Simon J. Dovedi. 2025. “Innovative strategies for T cell engagers for cancer immunotherapy.” mAbs 17 (1): 2531223. https://doi.org/10.1080/19420862.2025.2531223.
Harvard
Bergamaschi, C. et al. (2025) ‘Innovative strategies for T cell engagers for cancer immunotherapy’, mAbs, 17(1), p. 2531223. doi:10.1080/19420862.2025.2531223.
IEEE
C. Bergamaschi et al., “Innovative strategies for T cell engagers for cancer immunotherapy,” mAbs, vol. 17, no. 1, p. 2531223, 2025, doi: 10.1080/19420862.2025.2531223.
BibTeX
@article{bergamaschi2025innovative,
title = {{Innovative strategies for T cell engagers for cancer immunotherapy}},
author = {Bergamaschi, Cristina and Gaspar, Miguel A. and Ciucci, Thomas and Sitnikova, Suzanne I. and Cayatte, Corinne and Pica, Mike and Dovedi, Simon J.},
journal = {mAbs},
year = {2025},
volume = {17},
number = {1},
pages = {2531223},
doi = {10.1080/19420862.2025.2531223},
url = {https://doi.org/10.1080/19420862.2025.2531223}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- T-cell engagers
- cancer immunotherapy
- cytokine release syndrome
- on-target off-tumor toxicity
- immunological synapse
- T cell subsets
- tumor microenvironment
- costimulation
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Bergamaschi, C., Gaspar, M. A., Ciucci, T., Sitnikova, S. I., Cayatte, C., Pica, M., & Dovedi, S. J. (2025). Innovative strategies for T cell engagers for cancer immunotherapy. mAbs, 17(1), 2531223. https://doi.org/10.1080/19420862.2025.2531223
How many times has this paper been cited?
43 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at mAbs: sign in and open the PDF from this page.
Who wrote this paper?
Cristina Bergamaschi, Miguel A. Gaspar, Thomas Ciucci, Suzanne I. Sitnikova, Corinne Cayatte, Mike Pica, Simon J. Dovedi.
What is the DOI of this paper?
10.1080/19420862.2025.2531223, permanently at https://doi.org/10.1080/19420862.2025.2531223. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.